BAYER INTELLECTUAL PROPERTY GMBH;LEAD DISCOVERY CENTER GMBH
发明人:
申请号:
IL22122912
公开号:
IL221229A
申请日:
2012.08.01
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase.